Login / Signup

Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32-week real-world experience during the COVID-19 pandemic.

K HanselC PatrunoE AntonelliGiacomo Dal BelloMaddalena NapolitanoG FabbrociniT GriecoG PellacaniMaria-Concetta FargnoliM EspositoV PirasM ZuccaG GirolomoniLuca Stingeni
Published in: Clinical and experimental dermatology (2021)
Keyphrases
  • atopic dermatitis
  • young adults
  • physical activity
  • high intensity
  • early onset
  • placebo controlled
  • drug induced
  • clinical trial
  • randomized controlled trial